AIM
ABBV icon

Achmea Investment Management’s AbbVie ABBV Stock Holding History

Achmea Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.5M Sell
327,773
-37,869
-10% -$8.15M 2.06% 9
2026
Q1 		$79.5M Buy
365,642
+15,200
+4% +$3.37M 2.1% 9
2025
Q4 		$80.1M Sell
350,442
-13,897
-4% -$3.17M 2.04% 8
2025
Q3 		$84.4M Buy
364,339
+5,767
+2% +$1.17M 1.05% 12
2025
Q2 		$66.6M Buy
358,572
+4,327
+1% +$804K 0.86% 18
2025
Q1 		$74.2M Buy
354,245
+23,585
+7% +$4.59M 1.08% 11
2024
Q4 		$58.8M Sell
330,660
-5,460
-2% -$1M 0.97% 12
2024
Q3 		$66.4M Buy
336,120
+9,495
+3% +$1.77M 1.09% 11
2024
Q2 		$56M Buy
326,625
+18,304
+6% +$3.03M 1% 16
2024
Q1 		$56.1M Buy
308,321
+38,470
+14% +$6.63M 1.07% 12
2023
Q4 		$41.8M Sell
269,851
-16,009
-6% -$2.33M 0.86% 21
2023
Q3 		$42.6M Sell
285,860
-2,128
-0.7% -$312K 0.93% 18
2023
Q2 		$38.8M Buy
287,988
+33,590
+13% +$4.93M 0.82% 20
2023
Q1 		$40.5M Buy
254,398
+21,847
+9% +$3.34M 1.18% 11
2022
Q4 		$35.2M Buy
232,551
+5,175
+2% +$793K 1.18% 12
2022
Q3 		$30.5M Buy
+227,376
New +$32.6M 1.08% 14
2022
Q2 		– Sell
-193,214
Closed -$31.3M – 633
2022
Q1 		$31.3M Buy
193,214
+25,860
+15% +$3.76M 0.82% 20
2021
Q4 		$22.7M Buy
167,354
+37,093
+28% +$4.38M 1.08% 15
2021
Q3 		$14.1M Sell
130,261
-23,575
-15% -$2.69M 0.43% 45
2021
Q2 		$17.3M Sell
153,836
-18,384
-11% -$2.07M 0.59% 32
2021
Q1 		$18.6M Sell
172,220
-17,222
-9% -$1.84M 0.65% 27
2020
Q4 		$20.3M Buy
189,442
+5,859
+3% +$563K 0.73% 24
2020
Q3 		$16.1M Sell
183,583
-344,770
-65% -$32.5M 0.67% 25
2020
Q2 		$51.9M Buy
+528,353
New +$46.5M 1.76% 14
2020
Q1 		– Sell
-151,369
Closed -$13.4M – 257
2019
Q4 		$13.4M Sell
151,369
-30,924
-17% -$2.57M 0.52% 43
2019
Q3 		$13.8M Buy
182,293
+15,745
+9% +$1.08M 0.54% 39
2019
Q2 		$12.1M Buy
166,548
+2,413
+1% +$190K 0.46% 46
2019
Q1 		$13.2M Sell
164,135
-2,811
-2% -$230K 0.55% 43
2018
Q4 		$15.4M Sell
166,946
-90,788
-35% -$7.98M 0.71% 27
2018
Q3 		$24.4M Sell
257,734
-28,351
-10% -$2.69M 0.92% 19
2018
Q2 		$26.5M Buy
286,085
+44,075
+18% +$4.3M 0.93% 21
2018
Q1 		$22.9M Sell
242,010
-15,023
-6% -$1.65M 0.77% 25
2017
Q4 		$24.9M Buy
257,033
+140,860
+121% +$13.3M 0.84% 25
2017
Q3 		$10.3M Buy
116,173
+1,620
+1% +$123K 0.59% 34
2017
Q2 		$8.3M Sell
114,553
-6,156
-5% -$414K 0.5% 41
2017
Q1 		$7.87M Buy
+120,709
New +$7.59M 0.37% 62

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Achmea Investment Management's ABBV Position: Q2 2026 in Review

Achmea Investment Management reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $8.15M and leaving 327,773 shares worth $82.5M. The position accounts for 2.06% of the portfolio, ranked #9.

Achmea Investment Management first reported a position in ABBV in Q1 2017 and has held it in 36 quarters since. The position peaked at $84.4M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Achmea Investment Management held 327,773 shares of AbbVie worth $82.5M as of Q2 2026.
  • Achmea Investment Management sold 37,869 AbbVie shares in Q2 2026, an estimated $8.15M.
  • AbbVie made up 2.06% of Achmea Investment Management's portfolio in Q2 2026, its #9 holding.
  • Achmea Investment Management first reported a position in AbbVie in Q1 2017 and has held it in 36 quarters since.
  • Achmea Investment Management's AbbVie position peaked at $84.4M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.